Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 2 |
2005 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response.
J Exp Med. 2005 May 16;201(10):1591-602. doi: 10.1084/jem.20042167. Epub 2005 May 9.
J Exp Med. 2005.
PMID: 15883172
Free PMC article.
HER-2/neu-specific monoclonal antibodies collaborate with HER-2/neu-targeted granulocyte macrophage colony-stimulating factor secreting whole cell vaccination to augment CD8+ T cell effector function and tumor-free survival in Her-2/neu-transgenic mice.
Wolpoe ME, Lutz ER, Ercolini AM, Murata S, Ivie SE, Garrett ES, Emens LA, Jaffee EM, Reilly RT.
Wolpoe ME, et al.
J Immunol. 2003 Aug 15;171(4):2161-9. doi: 10.4049/jimmunol.171.4.2161.
J Immunol. 2003.
PMID: 12902523
Item in Clipboard
Identification and characterization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice.
Ercolini AM, Machiels JP, Chen YC, Slansky JE, Giedlen M, Reilly RT, Jaffee EM.
Ercolini AM, et al.
J Immunol. 2003 Apr 15;170(8):4273-80. doi: 10.4049/jimmunol.170.8.4273.
J Immunol. 2003.
PMID: 12682262
Item in Clipboard
Cite
Cite